References to the first quarters of 2018 and 2017 represent the fiscal quarters ended December 31, 2017 and 2016, respectively.
The Companyâ€™s results for the three-month periods ended December 31, 2017 are not necessarily indicative of the results for the entire 2018 fiscal year.
Valuation was based on third party evidence of similarly priced derivative instruments.
Compensation expense related to the restricted share awards was $1.1 million and $1.2 million for the three-month periods ended December 31, 2017 and 2016, respectively.
Compensation expense related to the non-employee director grants was $0.3 million and $0.2 million for the three-month periods ended December 31, 2017 and 2016, respectively.
The weighted average interest rates were 2.74% and 1.61% for the three-month periods ending December 31, 2017 and 2016, respectively.
The bank syndication supporting the facility is comprised of a diverse group of nine banks led by JPMorgan Chase Bank, N.A., as Administrative Agent.
The interest rate swaps entered into during the first quarter of 2018 were not designated as cash flow hedges and, therefore, the gain or loss on the derivative is reflected in earnings each period.The increase in net sales in the first quarter of 2018 as compared to the first quarter of 2017 was due to a $20.2 million increase in the USG segment, a $3.7 million increase in the Test segment, a $2.0 million increase in the Technical Packaging segment and a $1.2 million increase in the Filtration segment.
In the first quarter of 2018, net sales of $37.5 million were $3.7 million, or 10.9%, higher than the $33.8 million recorded in the first quarter of 2017.
In the first quarter of 2018, net sales of $20.2 million were $2.0 million, or 10.9% higher than the $18.2 million recorded in the first quarter of 2017.
Net sales increased $27.1 million, or 18.5%, to $173.5 million in the first quarter of 2018 from $146.4 million in the first quarter of 2017.
Net sales increased $20.2 million, or 56.8%, to $55.8 million in the first quarter of 2018 from $35.6 million in the first quarter of 2017.
EBIT was $15.0 million (8.6% of net sales) for the first quarter of 2018 compared to $16.8 million (11.5% of net sales) for the first quarter of 2017.
EBIT in the first quarter of 2018 was $1.0 million (4.8% of net sales) compared to $1.0 million (5.7% of net sales) in the first quarter of 2017.
EBIT in the first quarter of 2018 was $10.7 million (19.1% of net sales) compared to $9.7 million (27.1% of net sales) in the first quarter of 2017.
EBIT in the first quarter of 2018 was $2.6 million (6.9% of net sales) compared to $2.4 million (7.2% of net sales) in the first quarter of 2017.The interest rate swaps entered into during the first quarter of 2018 were not designated as cash flow hedges and, therefore, the gain or loss on the derivative is reflected in earnings each period.